Digital health, such as mobile health (mHealth) technologies, wearable devices, and telemedicine, has enormous potential for improving prevention, diagnosis, and treatment of disease and increasing access to health information and healthcare. Digital health could potentially exacerbate health inequities given unequal access to technology and disparities in digital literacy across social groups [Reference Jaworski, Webb Hooper and Aklin1]. For example, there is evidence from the COVID-19 pandemic that minoritized groups (e.g., Black, Latinx, and Indigenous patients), Non-English speakers, and those with low incomes had less access to telemedicine than non-Hispanic whites [Reference Lau, Anand, Ramirez and Phicil2–Reference Shaw, Brewer and Veinot5]. However, there is also a tremendous opportunity for Clinical and Translational Scientists to promote health equity with digital health by applying a health equity lens to the development, implementation, and evaluation of these approaches. Applying a health equity lens is a reflective process aimed at considering how digital health technologies may exacerbate health disparities focusing on those approaches that will lessen health disparities. The translational science community can play an important role in applying a health equity lens to digital health through education and training for clinical and translational scientists, the provision of resources, and policy change.
Education and training for clinical and translational scientists can leverage existing frameworks for digital health equity [Reference Richardson, Lawrence, Schoenthaler and Mann6,Reference Jahnel, Dassow, Gerhardus and Schüz7]. Two recently published frameworks are recommended for ensuring digital health interventions are inclusive, accessible, and beneficial: the Digital Health Equity Framework (Figure 1) [Reference Richardson, Lawrence, Schoenthaler and Mann6] and the Digital Rainbow Model (Figure 2) [Reference Jahnel, Dassow, Gerhardus and Schüz7]. The Digital Health Equity Framework builds on the National Institute on Minority Health and Health Disparities research framework [Reference Alvidrez, Castille, Laude-Sharp, Rosario and Tabor8] and emphasizes upstream approaches to scaling and implementing digital health interventions by focusing on factors impacting access and utilization such as broadband access, digital literacy, and cultural relevance. The Digital Rainbow Model has greater emphasis on social identity and participatory approaches [Reference Jahnel, Dassow, Gerhardus and Schüz7]. Educational approaches (i.e., seminars, workshops, graduate course work, faculty trainings) grounded in these frameworks can guide researchers to consider structural, social, and environmental factors related to the digital divide in the development and implementation of new tools and technologies. For example, approaches guided by this framework could include providing hotspots to increase access to broadband for patients or digital navigators who can address barriers to technology access [Reference Adedinsewo, Eberly, Sokumbi, Rodriguez, Patten and Brewer9]. Professional organizations can provide training in theory-supported strategies for digital health equity in their specific domains. For example, the Society of Behavioral Medicine recently held a two-part webinar series: part I focused on design and implementation and part II focused on evaluation and dissemination. Key recommendations across both webinars centered on the idea that one size does not fit all with digital health interventions or programs. Community engagement, user-centered design, flexibility with technology options, digital health literacy, and resource allocation are essential elements of equitable digital health.
Applying a health equity lens to digital health requires resources that can be supported through Clinical and Translational Science Awards at Academic Medical Centers. Resources include those that support community and patient engagement in all stages of research including the development of digital tools, such as the Patient-Centered Outcomes Research Institute (PCORI) engagement rubric [Reference Sheridan, Schrandt, Forsythe, Hilliard and Paez10]. Engaging patients and communities with lived experience holds enormous potential for unlocking innovative approaches to promoting health equity, including those using digital health approaches. Resources for supporting patient and community engagement can include support in identifying appropriate partners, seed grants for developing and sustaining partnerships, and funding for engaging partners in developing and pilot-testing digital tools. Additionally, several national and international organizations have community-centered digital health guidelines including the Patient-Centered Outcomes Research Institute (PCORI) [11] and World Health Organization [12]. Another useful resource is the digital health checklist which guides health researchers to consider key digital health issues during project development including access, usability, privacy, data management, and risks/benefits [13]. Developed by digital health experts and grounded in ethical research principles, this checklist is now freely available online.
Lastly, Academic Medical Centers, funders, journals, and others can implement programs and policies that support digital health equity. For example, Academic Medical Centers, with the support of Clinical and Translational Science Awards, can provide programs that support and provide resources to researchers and their community/patient partners to address technology access and literacy issues at the outset of research projects. Publishers can motivate researchers to address digital health equity by requiring reporting on strategies used to address the digital health domains of influence. The journals Annals of Behavioral Medicine, Translational Behavioral Medicine, and all journals within the Journal of the American Medical Association network have recently implemented mandatory reporting on all categories of gender, race, ethnicity, and age for all research participants [Reference Frey14]. Presently, there are few reporting standards related to digital health intervention development (i.e., community engagement methods used); thus, more scientific bodies and professional organizations should mandate greater transparency [Reference Shaw, Brewer and Veinot5,Reference Tan, Wu and Day15].
Two recent community-based clinical trials highlight best practices through all stages of the research process when deploying digital health interventions in partnership with under-represented racial and ethnic minority populations. First, the FAITH! (Fostering African American Improvement in Total Health!) Trial was a cluster randomized controlled trial assessing the feasibility and preliminary efficacy of an mHealth intervention called the FAITH! App to promote cardiovascular health among African American adults (N = 85) [Reference Brewer, Jenkins and Hayes16]. This multi-funder-supported project (Clinical and Translational Science Awards program, American Heart Association, and NIMHD) transitioned an in-person cardiovascular health and wellness program into a smartphone app. Participatory design was used to co-translate the program with community members through an iterative process via focus groups. Potential end-user feedback enhanced the usability and satisfaction prior to rigorously testing the app’s impact on cardiovascular health. Guided by principles of digital health social justice [Reference Figueroa, Murayama and Amorim17], the app development process accounted for issues of accessibility, data security, and community technology norms. The second example of applied health equity best practices when conducting digital health interventions is the Hombre Trial [Reference Rosas, Lv and Xiao18]. This PCORI-funded randomized controlled study tested a culturally adapted intervention to promote weight loss in Latino men with overweight or obesity (N = 424). The intervention allowed the men to self-select on how to receive the coach-facilitated group sessions intervention: in-person, through videoconferencing, or viewing pre-recorded group sessions [Reference Rosas, Lv and Xiao19]. Allowing the men to choose the delivery mode was key to engaging this historically marginalized population and was only possible through formative work pilot-testing of the video conferencing. Both exemplar projects integrated advisory boards comprised of community and patient stakeholders who, through regular contact with the research team, advised on cultural adaptations of the interventions through semi-structured interviews, discussion forums, and focus groups. In both examples, flexibility with design and approach was key to recruiting and retaining participants. Notably, both case examples demonstrated clinically significant changes in health outcomes with at-risk populations who are largely under-represented in clinical and translational research.
In conclusion, digital health technologies offer great potential for improving healthcare access, delivery, and outcomes. Clinical and translational scientists are called to apply a health equity lens to the development and evaluation of digital health technologies to avoid exacerbating current health inequities and to increase the potential that these approaches will contribute to promoting health equity. This includes seeking out educational opportunities in digital health equity, especially those that use evidence-based frameworks [Reference Lau, Anand, Ramirez and Phicil2,Reference Tong, George and Crotty3], and engaging those with lived experience in all phases of the research process to develop and evaluate digital health technologies. It is especially important to share methods and findings from engaging those with lived experience in the research process on digital health so that others can learn from and build on this knowledge. Finally, we also call on Academic Medical Centers, funders, and professional societies to provide educational opportunities and resources for applying an equity lens to the field of digital health.
Author contributions
All three authors contributed to Conceptualization, Writing-Original Draft, Writing-Review and editing.
Funding statement
LaPrincess C. Brewer was supported by the AHA Second Century Implementation Science award (grant 23SCISA1144689), the Robert A. Winn Career Development award (Bristol Myers Squibb Foundation), the National Institutes of Health (NIH) and the National Institute on Minority Health and Health Disparities (grant P50MD017342), and the clinical and translational science awards (grant UL1 TR000135) from the National Center for Advancing Translational Sciences (NCATS) to Mayo Clinic during the implementation of this work. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCATS or NIH. Lisa G. Rosas was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR003142. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
Competing interests
The authors do not have competing interests to report.